NFKB2
MOLECULAR TARGETnuclear factor kappa B subunit 2
NFKB2 (nuclear factor kappa B subunit 2) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NFKB2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Quercetin | 2.08 | 7 |
| 2 | Bortezomib | 1.10 | 2 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 4 | Kaempferols | 0.69 | 1 |
| 5 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 6 | Resveratrol | 0.69 | 1 |
| 7 | Rutin | 0.69 | 1 |
| 8 | Withania | 0.69 | 1 |
| 9 | isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from | 0.69 | 1 |
| 10 | tamarixetin | 0.69 | 1 |
| 11 | withaferin | 0.69 | 1 |
About NFKB2 as a Drug Target
NFKB2 (nuclear factor kappa B subunit 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented NFKB2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NFKB2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.